Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Metz

Showing results (41-50 of 256) with videos related to

Pageof 26
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 17, 2013
Revisions to the international guidelines on the diagnosis and therapy of chronic urticariaMarcus Maurer, Markus Magerl, Martin Metz, et al.
Allergy|August 25, 2019
New biological treatments for asthma and skin allergiesStefanie Eyerich, Martin Metz, Apostolos Bossios, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 24, 2014
Mast cell-mediated reactions in vivoVladimir Andrey Giménez-Rivera, Martin Metz, Frank Siebenhaar
Clinical and Translational Allergy|April 11, 2017
Erratum to: Looking forward to new targeted treatments for chronic spontaneous urticariaEmek Kocatürk, Marcus Maurer, Martin Metz, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 4, 2023
Livid papules at the distal extremities in a 14-year-old girlHanna Bonnekoh, Alexander Nast, Martin Metz, et al.
Allergy|March 13, 2026
Legends of Allergology/Immunology: Marcus Maurer (†)-Physician, Scientist, Allergist and Unbeatable CommunicatorLudger Klimek, Martin Metz, Petra Staubach, et al.
Immunological Reviews|February 13, 2018
The role and relevance of mast cells in urticariaMartin K Church, Pavel Kolkhir, Martin Metz, et al.
JAMA Dermatology|January 31, 2014
Retreatment with omalizumab results in rapid remission in chronic spontaneous and inducible urticariaMartin Metz, Tatevik Ohanyan, Martin K Church, et al.
Journal of Dermatological Science|September 25, 2013
Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysisMartin Metz, Tatevik Ohanyan, Martin K Church, et al.
Medecine Sciences : M/S|February 28, 2014
[An allergic response to fight against venoms]Thomas Marichal, Philipp Starkl, Martin Metz, et al.
Pageof 26

Showing results (41-50 of 256) with videos related to

Sort By:
Pageof 26
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 17, 2013
Revisions to the international guidelines on the diagnosis and therapy of chronic urticariaMarcus Maurer, Markus Magerl, Martin Metz, et al.
Allergy|August 25, 2019
New biological treatments for asthma and skin allergiesStefanie Eyerich, Martin Metz, Apostolos Bossios, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 24, 2014
Mast cell-mediated reactions in vivoVladimir Andrey Giménez-Rivera, Martin Metz, Frank Siebenhaar
Clinical and Translational Allergy|April 11, 2017
Erratum to: Looking forward to new targeted treatments for chronic spontaneous urticariaEmek Kocatürk, Marcus Maurer, Martin Metz, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 4, 2023
Livid papules at the distal extremities in a 14-year-old girlHanna Bonnekoh, Alexander Nast, Martin Metz, et al.
Allergy|March 13, 2026
Legends of Allergology/Immunology: Marcus Maurer (†)-Physician, Scientist, Allergist and Unbeatable CommunicatorLudger Klimek, Martin Metz, Petra Staubach, et al.
Immunological Reviews|February 13, 2018
The role and relevance of mast cells in urticariaMartin K Church, Pavel Kolkhir, Martin Metz, et al.
JAMA Dermatology|January 31, 2014
Retreatment with omalizumab results in rapid remission in chronic spontaneous and inducible urticariaMartin Metz, Tatevik Ohanyan, Martin K Church, et al.
Journal of Dermatological Science|September 25, 2013
Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysisMartin Metz, Tatevik Ohanyan, Martin K Church, et al.
Medecine Sciences : M/S|February 28, 2014
[An allergic response to fight against venoms]Thomas Marichal, Philipp Starkl, Martin Metz, et al.
Pageof 26